Ken Griffin Petmed Express Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.94 - $4.04 $12,054 - $16,564	4,100 Added 89.13%	8,700 $32,000
Q2 2024 Aug 14, 2024	SELL	$3.95 - $4.84 $28,045 - $34,364	-7,100 Reduced 60.68%	4,600 $18,000
Q1 2024 May 15, 2024	SELL	$4.7 - $7.58 $32,430 - $52,302	-6,900 Reduced 37.1%	11,700 $56,000
Q4 2023 Feb 14, 2024	SELL	$6.89 - $11.04 $17,225 - $27,599	-2,500 Reduced 11.85%	18,600 $140,000
Q3 2023 Nov 14, 2023	BUY	$10.21 - $14.65 $3,063 - $4,395	300 Added 1.44%	21,100 $216,000
Q2 2023 Aug 14, 2023	SELL	$13.68 - $16.56 $2,736 - $3,311	-200 Reduced 0.95%	20,800 $286,000
Q1 2023 May 15, 2023	SELL	$15.9 - $22.22 $322,770 - $451,066	-20,300 Reduced 49.15%	21,000 $341,000
Q4 2022 Feb 14, 2023	SELL	$17.16 - $22.14 $444,444 - $573,426	-25,900 Reduced 38.54%	41,300 $731,000
Q3 2022 Nov 14, 2022	BUY	$19.35 - $23.52 $36,765 - $44,688	1,900 Added 2.91%	67,200 $1.31 Million

102

9.52M

39.6K

137K

Ticker PETS
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 21,013,800
Market Cap $98.8M
Description
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint c...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.